PRDM12

gene
On this page

Also known as PFM9

Summary

PRDM12 (PR/SET domain 12, HGNC:13997) is a protein-coding gene on chromosome 9q34.12, encoding PR domain zinc finger protein 12 (Q9H4Q4). Transcriptional regulator necessary for the development of nociceptive neurons, playing a key role in determining the nociceptive lineage from neural crest cell progenitors.

This gene encodes a transcriptional regulator of sensory neuronal specification that plays a critical role in pain perception. The encoded protein contains an N-terminal PRDI-BF1 and RIZ homology (PR) domain, a SET domain, and three C-terminal C2H2 zinc finger DNA-binding domains. Naturally occurring mutations in this gene are associated with congenital insensitivity to pain (CIP), and hereditary sensory and autonomic neuropathies (HSAN’s) affecting peripheral sensory and autonomic neurons. Deregulation of this gene is associated with solid cancers and hematological malignancies including chronic myeloid leukaemia.

Source: NCBI Gene 59335 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): hereditary sensory and autonomic neuropathy (Definitive, GenCC) — +1 more curated relationship
  • GWAS associations: 2
  • Clinical variants (ClinVar): 293 total — 11 pathogenic, 4 likely-pathogenic
  • Phenotypes (HPO): 18
  • Druggable target: yes
  • MANE Select transcript: NM_021619

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13997
Approved symbolPRDM12
NamePR/SET domain 12
Location9q34.12
Locus typegene with protein product
StatusApproved
AliasesPFM9
Ensembl geneENSG00000130711
Ensembl biotypeprotein_coding
OMIM616458
Entrez59335

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000253008, ENST00000676323

RefSeq mRNA: 1 — MANE Select: NM_021619 NM_021619

CCDS: CCDS6934

Canonical transcript exons

ENST00000253008 — 5 exons

ExonStartEnd
ENSE00000868121130664594130664876
ENSE00000868122130666608130666798
ENSE00000868123130668158130668313
ENSE00000868124130678529130678640
ENSE00001052791130681248130682983

Expression profiles

Bgee: expression breadth broad, 41 present calls, max score 88.71.

Top tissues by expression

215 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
type B pancreatic cellCL:000016988.71gold quality
buccal mucosa cellCL:000233686.87gold quality
olfactory bulbUBERON:000226485.10gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451180.28silver quality
cervix squamous epitheliumUBERON:000692278.72gold quality
diaphragmUBERON:000110377.20gold quality
vena cavaUBERON:000408776.82silver quality
vastus lateralisUBERON:000137976.48gold quality
thymusUBERON:000237076.22silver quality
skeletal muscle tissue of biceps brachiiUBERON:000450275.92gold quality
tracheaUBERON:000312675.16gold quality
substantia nigra pars compactaUBERON:000196574.95silver quality
triceps brachiiUBERON:000150974.71gold quality
cerebellar vermisUBERON:000472074.67gold quality
cardia of stomachUBERON:000116274.34gold quality
pericardiumUBERON:000240774.34silver quality
biceps brachiiUBERON:000150774.15gold quality
lateral nuclear group of thalamusUBERON:000273674.05gold quality
ponsUBERON:000098873.98gold quality
pylorusUBERON:000116673.93gold quality
superior surface of tongueUBERON:000737173.83gold quality
penisUBERON:000098973.13silver quality
male germ cellCL:000001572.86gold quality
renal medullaUBERON:000036272.81gold quality
globus pallidusUBERON:000187572.36silver quality
cervix epitheliumUBERON:000480172.04gold quality
medial globus pallidusUBERON:000247771.93silver quality
gluteal muscleUBERON:000200071.83gold quality
tongue squamous epitheliumUBERON:000691971.80gold quality
spermCL:000001971.73gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.48

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

50 targeting PRDM12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-656-3P100.0072.152788
HSA-MIR-4283100.0066.422097
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-493-5P99.9672.472382
HSA-MIR-1236-3P99.9468.041695
HSA-MIR-381-3P99.9371.872854
HSA-MIR-30099.9271.762856
HSA-MIR-367199.9073.043897
HSA-MIR-449299.8768.253611
HSA-MIR-5003-3P99.8569.292517
HSA-MIR-205-5P99.8170.051557
HSA-MIR-57799.7869.132479
HSA-MIR-129999.7771.242389
HSA-MIR-4699-3P99.7170.153142
HSA-MIR-128499.6773.561353
HSA-MIR-6751-5P99.5664.991145
HSA-MIR-360999.5269.892587
HSA-MIR-548AH-5P99.5269.732626
HSA-MIR-582-5P99.4770.792635
HSA-MIR-889-3P99.4069.762103
HSA-MIR-318299.4068.152454
HSA-MIR-317699.2564.35954
HSA-MIR-3922-3P99.2564.961136
HSA-MIR-6803-5P99.1963.901026

Literature-anchored findings (GeneRIF, showing 7)

  • Down-regulation of PRDM12 is associated with the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion (PMID:14523459)
  • PRDM12 and its functional fly homolog Hamlet are evolutionary conserved master regulators of sensory neuronal specification and play a critical role in pain perception (PMID:25891934)
  • Prdm12 is a key factor in the orchestration of sensory neurogenesis. (PMID:26005867)
  • The natural history of the PRDM12-CIP disorder. (PMID:26975306)
  • Study in five further children, from four families, with facial lesions typical of midface toddler excoriation syndrome (MiTES) found autosomal recessive mutations in PRDM12 in four of five patients and extended the phenotypic spectrum of PRDM12 mutations, which usually cause hereditary sensory and autonomic neuropathy type VIII, characterized by mutilating self-inflicted wounds of the extremities, lips and tongue. (PMID:29949203)
  • PRDM12 in Health and Diseases. (PMID:34769459)
  • Ocular manifestations among patients with congenital insensitivity to pain due to variants in PRDM12 and SCN9A genes. (PMID:36111846)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioprdm12bENSDARG00000007430
mus_musculusPrdm12ENSMUSG00000079466
rattus_norvegicusPrdm12ENSRNOG00000009218

Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)

Protein

Protein identifiers

PR domain zinc finger protein 12Q9H4Q4 (reviewed: Q9H4Q4)

Alternative names: PR domain-containing protein 12

All UniProt accessions (2): Q9H4Q4, A0A6Q8PH01

UniProt curated annotations — full annotation on UniProt →

Function. Transcriptional regulator necessary for the development of nociceptive neurons, playing a key role in determining the nociceptive lineage from neural crest cell progenitors. Initiates neurogenesis and activates downstream pro-neuronal transcription factors, such as NEUROD1, BRN3A, and ISL1, specifically within nociceptive neurons, while repressing non-nociceptor cell fates. Essential for the proper function of nociceptors in adults, influencing both their excitability and their gene expression, thereby impacting how these neurons respond to various pain stimuli.

Subunit / interactions. Interacts with EHMT2.

Subcellular location. Nucleus.

Tissue specificity. Not found in adult tissues except in dorsal root ganglia.

Disease relevance. Neuropathy, hereditary sensory and autonomic, 8 (HSAN8) [MIM:616488] A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN8 patients manifest congenital insensitivity to pain resulting in ulceration to the fingers, tongue, lips, and other distal appendages. Some patients may also have decreased sweating and tear production. The disease is caused by variants affecting the gene represented in this entry.

Polymorphism. The poly-alanine tract is polymorphic in the general population and contains a maximum of 14 alanines.

Similarity. Belongs to the class V-like SAM-binding methyltransferase superfamily.

RefSeq proteins (1): NP_067632* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001214SET_domDomain
IPR013087Znf_C2H2_typeDomain
IPR017126Znf_PRDM12Family
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR044406PRDM12_PR/SETDomain
IPR046341SET_dom_sfHomologous_superfamily
IPR050331Zinc_finger_PRDM4/PRDM1/PRDM14Family

Pfam: PF00096, PF21549

UniProt features (26 total): strand 11, sequence variant 7, zinc finger region 3, chain 1, domain 1, helix 1, turn 1, region of interest 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
3EP0X-RAY DIFFRACTION2.1

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H4Q4-F164.810.12

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 147 (showing top): CREL_01, BENPORATH_ES_WITH_H3K27ME3, GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS, GOBP_NEUROGENESIS, EFC_Q6, NFKB_Q6, GOBP_SENSORY_PERCEPTION_OF_PAIN, CDP_01, GOBP_DETECTION_OF_TEMPERATURE_STIMULUS, ATF1_Q6, GOBP_NEURON_FATE_SPECIFICATION, TGANTCA_AP1_C, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, NKX22_01, TATA_C

GO Biological Process (10): negative regulation of transcription by RNA polymerase II (GO:0000122), protein methylation (GO:0006479), regulation of gene expression (GO:0010468), sensory perception of pain (GO:0019233), neurogenesis (GO:0022008), neuron projection development (GO:0031175), neuron fate specification (GO:0048665), detection of temperature stimulus involved in sensory perception of pain (GO:0050965), methylation (GO:0032259), positive regulation of transcription by RNA polymerase II (GO:0045944)

GO Molecular Function (11): DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), DNA binding (GO:0003677), zinc ion binding (GO:0008270), histone chaperone activity (GO:0140713), histone methyltransferase binding (GO:1990226), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), protein binding (GO:0005515), methyltransferase activity (GO:0008168), transferase activity (GO:0016740), metal ion binding (GO:0046872)

GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of transcription by RNA polymerase II3
RNA polymerase II transcription regulatory region sequence-specific DNA binding3
transcription by RNA polymerase II2
DNA-binding transcription factor activity, RNA polymerase II-specific2
negative regulation of DNA-templated transcription1
protein alkylation1
macromolecule methylation1
gene expression1
regulation of macromolecule biosynthetic process1
sensory perception1
nervous system development1
cell differentiation1
neuron development1
plasma membrane bounded cell projection organization1
cell fate specification1
neuron fate commitment1
sensory perception of pain1
detection of temperature stimulus involved in sensory perception1
metabolic process1
positive regulation of DNA-templated transcription1
negative regulation of transcription by RNA polymerase II1
DNA-binding transcription repressor activity1
DNA-binding transcription activator activity1
positive regulation of transcription by RNA polymerase II1
nucleic acid binding1
transition metal ion binding1
histone binding1
protein carrier activity1
enzyme binding1
chromatin1
DNA-binding transcription factor activity1
binding1
transferase activity, transferring one-carbon groups1
catalytic activity1
cation binding1
intracellular membrane-bounded organelle1
nuclear lumen1
cellular anatomical structure1

Protein interactions and networks

STRING

570 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PRDM12EHMT2Q96KQ7624
PRDM12DRGXA6NNA5575
PRDM12NEUROG1Q92886557
PRDM12PRDM11Q9NQV5542
PRDM12SCN11AQ9UI33505
PRDM12SCN9AQ15858476
PRDM12PHOX2BQ99453455
PRDM12ASIC3Q9UHC3448
PRDM12TRPV1Q8NER1445
PRDM12NEUROD2Q15784437
PRDM12DBX1A6NMT0424
PRDM12GPR101Q96P66413
PRDM12OR11L1Q8NGX0411
PRDM12POU4F1Q01851399
PRDM12EN1Q05925399

IntAct

2 interactions, top by confidence:

ABTypeScore
PRDM12SERPINB8psi-mi:“MI:0914”(association)0.350

BioGRID (3): PRDM12 (Affinity Capture-MS), SERPINB8 (Affinity Capture-MS), RUNX1T1 (Affinity Capture-MS)

ESM2 similar proteins: A0A140LI67, A0JN76, A1L2U9, A2A5N8, A2AJ77, A6QPM3, B1WAZ8, B8A5Y1, D3ZWK4, E9Q3T6, E9Q8T2, O15060, O88866, O94966, P0C2N6, P57058, Q05516, Q0IH98, Q0IJ29, Q3B725, Q3TES0, Q3UZD5, Q4R739, Q60760, Q68UT7, Q6NZK8, Q6P2A1, Q6P4K6, Q6Q783, Q6S5L9, Q6YND2, Q76M68, Q7ZWZ4, Q80X44, Q8BXX2, Q8N680, Q8NE63, Q96CK0, Q99592, Q9GZV8

Diamond homologs: A0A163UT06, A2A935, A2AGX3, A2AJ77, B8A5Y1, E9Q3T6, O75626, P0C6Y7, P14404, Q03112, Q13029, Q3UZD5, Q60636, Q63755, Q6P2A1, Q8BZ97, Q96EQ9, Q9GZV8, Q9H4Q4, Q9HAZ2, Q9NQV5, Q9NQV7, Q9NQV8, Q9NQW5, A6QPM3, Q9CXE0, Q9NQX0, Q9NQX1, E9PZZ1, Q9H4Q3, A2BID7, Q6DCW1, Q9VH70, B4F6U4, E9Q8T2, I7HJS4, P57071, Q3UTQ7, Q5R5M1, Q5RAX9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

293 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic11
Likely pathogenic4
Uncertain significance139
Likely benign102
Benign21

Top pathogenic / likely-pathogenic (15)

Variant IDHGVSClassification
1072417NM_021619.3(PRDM12):c.224-1G>APathogenic
1323492NM_021619.3(PRDM12):c.131_138del (p.Val44fs)Pathogenic
1332705NM_021619.3(PRDM12):c.785T>G (p.Met262Arg)Pathogenic
1745663NM_021619.3(PRDM12):c.514G>T (p.Glu172Ter)Pathogenic
253118NM_021619.3(PRDM12):c.1041CGC[(15_?)]Pathogenic
253120NM_021619.3(PRDM12):c.91G>T (p.Asp31Tyr)Pathogenic
253121NM_021619.3(PRDM12):c.516G>C (p.Glu172Asp)Pathogenic
253122NM_021619.3(PRDM12):c.866A>T (p.His289Leu)Pathogenic
2706647NM_021619.3(PRDM12):c.578dup (p.Pro194fs)Pathogenic
59908GRCh38/hg38 9q34.11-34.3(chr9:129068560-136495351)x3Pathogenic
916004GRCh37/hg19 9q34.12(chr9:133553916-133554028)Pathogenic
3773873NM_021619.3(PRDM12):c.455C>A (p.Ala152Asp)Likely pathogenic
430206NM_021619.3(PRDM12):c.811T>G (p.Phe271Val)Likely pathogenic
451909NM_021619.3(PRDM12):c.600_606delinsCA (p.Trp201fs)Likely pathogenic
848182NM_021619.3(PRDM12):c.1041CGC[18] (p.Ala354_Ala359dup)Likely pathogenic

SpliceAI

772 predictions. Top by Δscore:

VariantEffectΔscore
9:130666794:GGGAG:Gdonor_gain1.0000
9:130666795:GGAGG:Gdonor_gain1.0000
9:130666796:G:Tdonor_gain1.0000
9:130666797:AGG:Adonor_loss1.0000
9:130666799:G:Cdonor_loss1.0000
9:130668153:CCCA:Cacceptor_loss1.0000
9:130668156:A:AGacceptor_gain1.0000
9:130668156:A:Cacceptor_loss1.0000
9:130668157:G:GGacceptor_gain1.0000
9:130668157:GGT:Gacceptor_gain1.0000
9:130668269:G:GTdonor_gain1.0000
9:130668305:GCCAT:Gdonor_gain1.0000
9:130668314:G:GGdonor_loss1.0000
9:130668315:T:Adonor_loss1.0000
9:130678526:CAGAT:Cacceptor_loss1.0000
9:130678527:A:ACacceptor_loss1.0000
9:130678527:A:AGacceptor_gain1.0000
9:130678527:AGAT:Aacceptor_gain1.0000
9:130678528:G:GTacceptor_gain1.0000
9:130678528:GA:Gacceptor_gain1.0000
9:130678528:GAT:Gacceptor_gain1.0000
9:130678528:GATG:Gacceptor_gain1.0000
9:130678528:GATGA:Gacceptor_gain1.0000
9:130678636:GCATG:Gdonor_gain1.0000
9:130678638:ATG:Adonor_gain1.0000
9:130678639:TG:Tdonor_gain1.0000
9:130678640:GG:Gdonor_gain1.0000
9:130678640:GGT:Gdonor_loss1.0000
9:130678641:G:GCdonor_loss1.0000
9:130678641:G:GGdonor_gain1.0000

AlphaMissense

2410 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:130681298:T:CC245R1.000
9:130681307:T:CC248R1.000
9:130681308:G:AC248Y1.000
9:130681309:C:GC248W1.000
9:130681319:T:CF252L1.000
9:130681321:C:AF252L1.000
9:130681321:C:GF252L1.000
9:130681403:T:CF280L1.000
9:130681405:C:AF280L1.000
9:130681405:C:GF280L1.000
9:130666793:T:AW137R0.999
9:130666793:T:CW137R0.999
9:130668267:T:CL175P0.999
9:130668299:T:GY186D0.999
9:130678551:T:CL198P0.999
9:130681298:T:AC245S0.999
9:130681299:G:CC245S0.999
9:130681300:C:GC245W0.999
9:130681307:T:AC248S0.999
9:130681308:G:CC248S0.999
9:130681320:T:CF252S0.999
9:130681338:T:CL258P0.999
9:130681346:C:AH261N0.999
9:130681346:C:GH261D0.999
9:130681348:C:AH261Q0.999
9:130681348:C:GH261Q0.999
9:130681353:G:CR263P0.999
9:130681382:T:CC273R0.999
9:130681384:C:GC273W0.999
9:130681404:T:CF280S0.999

dbSNP variants (sampled 300 via entrez): RS1000316444 (9:130678275 T>C), RS1000329734 (9:130681788 G>C,T), RS1000524777 (9:130664059 G>A), RS1000537767 (9:130667728 G>A,T), RS1000675967 (9:130664004 C>A,G,T), RS1000862735 (9:130677372 G>A,T), RS1001020599 (9:130672258 A>G), RS1001121965 (9:130677591 G>T), RS1001126577 (9:130662743 G>T), RS1001190577 (9:130663164 G>A), RS1001193993 (9:130678328 G>A,C,T), RS1001417824 (9:130668670 C>A,T), RS1001429154 (9:130673298 G>A), RS1001712762 (9:130663176 AG>A), RS1001762614 (9:130673503 CTT>C,CT,CTTT)

Disease associations

OMIM: gene MIM:616458 | disease phenotypes: MIM:616488, MIM:162400

GenCC curated gene-disease

DiseaseClassificationInheritance
hereditary sensory and autonomic neuropathyDefinitiveAutosomal recessive
congenital insensitivity to pain-hypohidrosis syndromeDefinitiveAutosomal recessive

Mondo (2): congenital insensitivity to pain-hypohidrosis syndrome (MONDO:0014662), hereditary sensory and autonomic neuropathy (MONDO:0015364)

Orphanet (2): Hereditary sensory and autonomic neuropathy type 8 (Orphanet:478664), Hereditary sensory and autonomic neuropathy (Orphanet:140471)

HPO phenotypes

18 total (18 of 18 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000407Sensorineural hearing impairment
HP:0000559Corneal scarring
HP:0000633Decreased lacrimation
HP:0000966Hypohidrosis
HP:0001249Intellectual disability
HP:0001265Hyporeflexia
HP:0001581Recurrent skin infections
HP:0002495Impaired vibratory sensation
HP:0002579Gastrointestinal dysmotility
HP:0003593Infantile onset
HP:0004409Hyposmia
HP:0007021Pain insensitivity
HP:0010829Impaired temperature sensation
HP:0010831Impaired proprioception
HP:0011463Childhood onset
HP:0012804Corneal ulceration
HP:0033748Hypoesthesia

GWAS associations

2 associations (top):

StudyTraitp-value
GCST002304_7Fractional exhaled nitric oxide (childhood)5.000000e-06
GCST008839_9Height8.000000e-28

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0005536nitric oxide exhalation measurement

MeSH disease descriptors (1)

DescriptorNameTree numbers
D009477Hereditary Sensory and Autonomic NeuropathiesC10.500.250; C10.574.500.493; C10.668.829.800.175; C16.131.666.310; C16.320.400.415

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL5214854 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression, decreases methylation, increases methylation, increases mutagenesis3
Aflatoxin B1increases expression, increases methylation2
hydroxyhydroquinonedecreases expression, decreases reaction1
arseniteincreases methylation1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
ferrous chloridedecreases expression1
4-aminobenzhydrazidedecreases reaction, decreases expression1
abrinedecreases expression1
(+)-JQ1 compounddecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Decitabineincreases expression1
Acetaminophenincreases expression1
Air Pollutantsincreases abundance, increases expression1
Diethylhexyl Phthalateincreases expression1
Phthalic Acidsincreases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Progesteroneincreases expression1
Smokedecreases expression1
Urethanedecreases expression1
Valproic Aciddecreases expression, increases methylation1
Cadmium Chlorideincreases expression1
S-Nitrosoglutathioneincreases expression1
Particulate Matterincreases expression, increases abundance1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5214661BindingSelectivity interaction (Methyltransferase panel (DSF assay)) EUB0000234b PRDM12Selectivity Literature for EUbOPEN Chemogenomics Library wave 3

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_HC90HEK293 eGFP-PRDM12Transformed cell lineFemale

Clinical trials (associated diseases)

4 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT02624310PHASE2WITHDRAWNA Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis
NCT02696746Not specifiedUNKNOWNPainful Channelopathies Study
NCT03920774Not specifiedRECRUITINGThe Natural History of Familial Dysautonomia
NCT05527379Not specifiedCOMPLETEDInterest of Virtual Reality to Reduce Patient Anxiety During the Placement of a Percutaneous Implantable Port Catheter